Ahmad, F. A, Petrie, M. C, McMurray, J. J & Lang, NN. (2019). Personalized medicine and hospitalization for heart failure: If we understand it, we may be successful in treating it. European Journal of Heart Failure,21(6), 699-702. United Kingdom: John Wiley & Sons. Retrieved from https://doi.org/10.1002/ejhf.1463
Randomized trials in patients with hospitalized heart failure (HHF) continue to frustrate the cardiology community. Promising haemodynamic, structural and biomarker findings from phase 2 studies consistently fail to deliver substantive benefits in larger outcome trials. What underlies these recurrent failures? Why are persistently high readmission and post‐discharge mortality rates not being reduced? Challenging any pre‐conceived ideas about the existence of a ‘typical’ acutely decompensated heart failure patient is fundamental, as is the adoption of a carefully personalized approach. These individuals come from a remarkably heterogeneous group. Surely precise phenotyping should translate to a more successful therapeutic approach?
Mary MacKillop Institute for Health Research
Open Access Journal Article
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.